BMRN
BioMarin Pharmaceutical Inc.
NASDAQ · Healthcare · Biotechnology · US
$66.35
−0.12%Leverage
- Debt / equity
- 0.66x
- Net debt / equity
- 0.53x
- Debt / assets
- 0.36x
- Debt / EBITDA
- 10.90x
- Net debt / EBITDA
- 8.63x
Liquidity & coverage
- Current ratio
- 2.39x
- Quick ratio
- 1.32x
- Cash ratio
- 0.53x
- Interest coverage
- 3.27x
- EBITDA / interest
- 4.61x
- Working capital
- $2.3B
Cash & dividend
- FCF / debt
- 0.17x
- Cash flow / debt
- 0.20x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026